Melissa Bowers
Family Medicine · Beaufort, SCNPI 1023242625
Payments from drug & device makers
Across 78 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$309
- Lilly USA, LLC$191
- Novo Nordisk$170
- Dexcom, Inc.$94
- Merck$81
- Ultragenyx Pharmaceutical Inc.$74
- plus $472 from 17 others
What the payments were for
- Food & beverage$1,392100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $309 |
| Lilly USA, LLC | 12 | $191 |
| Novo Nordisk | 10 | $170 |
| Dexcom, Inc. | 3 | $94 |
| Merck | 6 | $81 |
| Ultragenyx Pharmaceutical Inc. | 3 | $74 |
| AbbVie(2 entities) | 3 | $60 |
| Radius Health, Inc. | 2 | $59 |
| Boston Scientific | 2 | $41 |
| GSK | 2 | $39 |
| Astellas Pharma US Inc | 2 | $33 |
| Organon | 2 | $32 |
| Novartis | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Johnson & Johnson | 2 | $26 |
| Pfizer | 2 | $24 |
| Abbott | 1 | $20 |
| Eisai Inc. | 1 | $16 |
| Innocoll Pharmaceuticals Limited | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| G Medical Diagnostic Services, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$1,392 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 68 | $75,935 |
| MounjaroTirzepatide | 68 | $72,155 |
| EliquisApixaban | 73 | $67,010 |
| FarxigaDapagliflozin Propanediol | 87 | $66,913 |
| JardianceEmpagliflozin | 62 | $57,750 |
| JanuviaSitagliptin Phosphate | 47 | $49,950 |
| XareltoRivaroxaban | 43 | $34,632 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $27,292 |
| TrulicityDulaglutide | 24 | $24,714 |
| RybelsusSemaglutide | 21 | $21,326 |
| LinzessLinaclotide | 24 | $18,682 |
| JanumetSitagliptin Phos/Metformin Hcl | 18 | $13,155 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $11,203 |
| GemtesaVibegron | 20 | $10,404 |
| MyrbetriqMirabegron | 14 | $9,513 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $170 | $97,26189 claims |
| Lilly USA, LLCMounjaro, Trulicity | $191 | $96,86992 claims |
| PfizerEliquis | $24 | $67,01073 claims |
| AstraZenecaFarxiga | $309 | $66,91387 claims |
| MerckJanuvia, Janumet | $81 | $63,10565 claims |
| Boehringer IngelheimJardiance | $12 | $57,75062 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $39 | $45,38470 claims |
| Johnson & JohnsonXarelto | $26 | $34,63243 claims |
| AbbVieLinzess | $60 | $18,68224 claims |
| Astellas Pharma US IncMyrbetriq | $33 | $9,51314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Beaufort
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.